RG
ADAP

Rathbones Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$104K Hold
432,818
﹤0.01% 587
2025
Q1
$85.3K Hold
432,818
﹤0.01% 563
2024
Q4
$233K Hold
432,818
﹤0.01% 507
2024
Q3
$411K Hold
432,818
﹤0.01% 437
2024
Q2
$422K Hold
432,818
﹤0.01% 439
2024
Q1
$684K Hold
432,818
﹤0.01% 373
2023
Q4
$343K Hold
432,818
﹤0.01% 455
2023
Q3
$338K Hold
432,818
﹤0.01% 457
2023
Q2
$400K Hold
432,818
﹤0.01% 320
2023
Q1
$472K Hold
432,818
﹤0.01% 304
2022
Q4
$632K Hold
432,818
0.01% 276
2022
Q3
$465K Hold
432,818
0.01% 290
2022
Q2
$736K Hold
432,818
0.01% 265
2022
Q1
$892K Hold
432,818
0.01% 259
2021
Q4
$1.62M Sell
432,818
-103
-0% -$386 0.02% 223
2021
Q3
$2.24M Hold
432,921
0.02% 198
2021
Q2
$1.84M Hold
432,921
0.02% 210
2021
Q1
$2.3M Hold
432,921
0.03% 186
2020
Q4
$2.33M Hold
432,921
0.03% 181
2020
Q3
$3.46M Sell
432,921
-10,000
-2% -$79.8K 0.06% 142
2020
Q2
$4.43M Buy
442,921
+44,068
+11% +$441K 0.09% 119
2020
Q1
$1.09M Sell
398,853
-303,722
-43% -$826K 0.03% 167
2019
Q4
$843K Hold
702,575
0.02% 202
2019
Q3
$1.06M Sell
702,575
-1,897
-0.3% -$2.87K 0.03% 187
2019
Q2
$2.83M Buy
704,472
+418,750
+147% +$1.68M 0.09% 121
2019
Q1
$1.23M Buy
285,722
+62,292
+28% +$268K 0.04% 163
2018
Q4
$1.29M Hold
223,430
0.05% 154
2018
Q3
$3.03M Sell
223,430
-20,000
-8% -$271K 0.1% 110
2018
Q2
$2.89M Hold
243,430
0.11% 113
2018
Q1
$2.73M Sell
243,430
-69,500
-22% -$781K 0.11% 114
2017
Q4
$2.09M Sell
312,930
-8,120
-3% -$54.2K 0.09% 129
2017
Q3
$2.63M Buy
321,050
+120,525
+60% +$987K 0.11% 118
2017
Q2
$900K Hold
200,525
0.04% 173
2017
Q1
$1.11M Hold
200,525
0.05% 156
2016
Q4
$812K Sell
200,525
-129,600
-39% -$525K 0.04% 168
2016
Q3
$2.33M Sell
330,125
-120,400
-27% -$849K 0.12% 108
2016
Q2
$3.67M Buy
450,525
+250,000
+125% +$2.04M 0.2% 84
2016
Q1
$1.63M Hold
200,525
0.1% 109
2015
Q4
$1.51M Buy
+200,525
New +$1.51M 0.1% 115